Elevated Expression of the Long Noncoding RNA MAFTRR in Patients with Hashimoto’s Thyroiditis

Background. Long noncoding RNAs (lncRNAs) represent an important novel class of noncoding RNA molecule greater than 200 nucleotides that play a key role in the regulation of autoimmune diseases. Previous studies have demonstrated that MAFTRR (MAF transcriptional regulator RNA) regulated Th1 cells di...

Full description

Saved in:
Bibliographic Details
Main Authors: Huiyong Peng, Xiangmei Ding, Juan Xu, Yue Han, Jun Yang, Xinyi Tang, Shengjun Wang, Yingzhao Liu
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2021/3577011
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850209336793497600
author Huiyong Peng
Xiangmei Ding
Juan Xu
Yue Han
Jun Yang
Xinyi Tang
Shengjun Wang
Yingzhao Liu
author_facet Huiyong Peng
Xiangmei Ding
Juan Xu
Yue Han
Jun Yang
Xinyi Tang
Shengjun Wang
Yingzhao Liu
author_sort Huiyong Peng
collection DOAJ
description Background. Long noncoding RNAs (lncRNAs) represent an important novel class of noncoding RNA molecule greater than 200 nucleotides that play a key role in the regulation of autoimmune diseases. Previous studies have demonstrated that MAFTRR (MAF transcriptional regulator RNA) regulated Th1 cells differentiation by inhibiting the expression of MAF in activated CD4+ T cells. However, the effect of MAFTRR on the pathogenesis of Hashimoto’s thyroiditis (HT) remains unclear. This research was aimed at investigating the expression of MAFTRR in Hashimoto’s thyroiditis (HT) as well as the correlation between MAFTRR and Th1 cells. Methods. Thirty-eight HT patients and thirty-eight healthy controls were enrolled in the study. The proportion of Th1 cells and CD8+IFN-γ+ T cells in peripheral blood mononuclear cells (PBMCs) from these specimens was determined by flow cytometric analysis. The transcript levels of MAFTRR, MAF, and IFNG in PBMCs and thyroid glands were detected by quantitative real-time PCR. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the potential value of MAFTRR in the HT patients. Results. We found that the proportion of circulating Th1 cells and the transcript levels of IFNG were increased in peripheral blood of the HT patients. The transcript levels of MAFTRR were significantly increased in the HT patients and positively correlated with the percentage of Th1 cells and serum levels of antithyroglobulin antibody and antithyroperoxidase antibody. The transcript levels of MAF, a transcription factor that inhibits Th1 cells activity and IFN-γ production, were attenuated in PBMCs from the HT patients. The transcript levels of IFNG had positive and inverse correlations with MAFTRR and MAF expression in PBMCs from the HT patients, respectively. Additionally, a significantly positive correlation between upregulated MAFTRR expression and augmented IFNG expression was revealed in thyroid tissues from the HT patients. ROC curve suggested that MAFTRR could potentially differentiate the HT patients from healthy controls. Conclusion. MAFTRR is significantly augmented in the HT patients and may contribute to the pathogenic role of the Th1 cells response in HT.
format Article
id doaj-art-91bbcee5614246ce9161b6b49f58f463
institution OA Journals
issn 2314-7156
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-91bbcee5614246ce9161b6b49f58f4632025-08-20T02:10:01ZengWileyJournal of Immunology Research2314-71562021-01-01202110.1155/2021/3577011Elevated Expression of the Long Noncoding RNA MAFTRR in Patients with Hashimoto’s ThyroiditisHuiyong Peng0Xiangmei Ding1Juan Xu2Yue Han3Jun Yang4Xinyi Tang5Shengjun Wang6Yingzhao Liu7Department of Laboratory MedicineDepartment of EndocrinologyDepartment of Critical Care MedicineDepartment of Laboratory MedicineDepartment of Laboratory MedicineDivision of Hematology and Internal MedicineDepartment of Laboratory MedicineDepartment of EndocrinologyBackground. Long noncoding RNAs (lncRNAs) represent an important novel class of noncoding RNA molecule greater than 200 nucleotides that play a key role in the regulation of autoimmune diseases. Previous studies have demonstrated that MAFTRR (MAF transcriptional regulator RNA) regulated Th1 cells differentiation by inhibiting the expression of MAF in activated CD4+ T cells. However, the effect of MAFTRR on the pathogenesis of Hashimoto’s thyroiditis (HT) remains unclear. This research was aimed at investigating the expression of MAFTRR in Hashimoto’s thyroiditis (HT) as well as the correlation between MAFTRR and Th1 cells. Methods. Thirty-eight HT patients and thirty-eight healthy controls were enrolled in the study. The proportion of Th1 cells and CD8+IFN-γ+ T cells in peripheral blood mononuclear cells (PBMCs) from these specimens was determined by flow cytometric analysis. The transcript levels of MAFTRR, MAF, and IFNG in PBMCs and thyroid glands were detected by quantitative real-time PCR. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the potential value of MAFTRR in the HT patients. Results. We found that the proportion of circulating Th1 cells and the transcript levels of IFNG were increased in peripheral blood of the HT patients. The transcript levels of MAFTRR were significantly increased in the HT patients and positively correlated with the percentage of Th1 cells and serum levels of antithyroglobulin antibody and antithyroperoxidase antibody. The transcript levels of MAF, a transcription factor that inhibits Th1 cells activity and IFN-γ production, were attenuated in PBMCs from the HT patients. The transcript levels of IFNG had positive and inverse correlations with MAFTRR and MAF expression in PBMCs from the HT patients, respectively. Additionally, a significantly positive correlation between upregulated MAFTRR expression and augmented IFNG expression was revealed in thyroid tissues from the HT patients. ROC curve suggested that MAFTRR could potentially differentiate the HT patients from healthy controls. Conclusion. MAFTRR is significantly augmented in the HT patients and may contribute to the pathogenic role of the Th1 cells response in HT.http://dx.doi.org/10.1155/2021/3577011
spellingShingle Huiyong Peng
Xiangmei Ding
Juan Xu
Yue Han
Jun Yang
Xinyi Tang
Shengjun Wang
Yingzhao Liu
Elevated Expression of the Long Noncoding RNA MAFTRR in Patients with Hashimoto’s Thyroiditis
Journal of Immunology Research
title Elevated Expression of the Long Noncoding RNA MAFTRR in Patients with Hashimoto’s Thyroiditis
title_full Elevated Expression of the Long Noncoding RNA MAFTRR in Patients with Hashimoto’s Thyroiditis
title_fullStr Elevated Expression of the Long Noncoding RNA MAFTRR in Patients with Hashimoto’s Thyroiditis
title_full_unstemmed Elevated Expression of the Long Noncoding RNA MAFTRR in Patients with Hashimoto’s Thyroiditis
title_short Elevated Expression of the Long Noncoding RNA MAFTRR in Patients with Hashimoto’s Thyroiditis
title_sort elevated expression of the long noncoding rna maftrr in patients with hashimoto s thyroiditis
url http://dx.doi.org/10.1155/2021/3577011
work_keys_str_mv AT huiyongpeng elevatedexpressionofthelongnoncodingrnamaftrrinpatientswithhashimotosthyroiditis
AT xiangmeiding elevatedexpressionofthelongnoncodingrnamaftrrinpatientswithhashimotosthyroiditis
AT juanxu elevatedexpressionofthelongnoncodingrnamaftrrinpatientswithhashimotosthyroiditis
AT yuehan elevatedexpressionofthelongnoncodingrnamaftrrinpatientswithhashimotosthyroiditis
AT junyang elevatedexpressionofthelongnoncodingrnamaftrrinpatientswithhashimotosthyroiditis
AT xinyitang elevatedexpressionofthelongnoncodingrnamaftrrinpatientswithhashimotosthyroiditis
AT shengjunwang elevatedexpressionofthelongnoncodingrnamaftrrinpatientswithhashimotosthyroiditis
AT yingzhaoliu elevatedexpressionofthelongnoncodingrnamaftrrinpatientswithhashimotosthyroiditis